Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 172

The DOI matches its Crossref record.

Pheochromocytoma in multiple endocrine neoplasia type 2: European study

Modigliani, E., VASEN, H. M., RAUE, K., DRALLE, H., FRILLING, A., GHERI, R. G., BRANDI, M. L., LIMBERT, E., NIEDERLE, B., FORGAS, L., ROSENBERG‐BOURGIN, M., CALMETTES, C., THE EUROMEN STUDY GROUP·1995·Journal of Internal Medicine

Abstract

Abstract. Objectives. Pheochromocytoma (pheo) is the second component of the multiple endocrine neoplasia type 2 (MEN 2) syndrome. Clinical expression is sometimes poor, and chronology between medullary thyroid carcinoma (MTC) and pheo is not well evaluated. Therefore, a retrospective study was done in eight European countries in order to precise the main characteristics of pheo in MEN 2. Subjects. Data from 300 MEN 2 patients with pheo (274 MEN 2 A and 26 MEN 2 B) were obtained from cases registered by the EuroMen study group, and collected by a medical standardized questionnaire. These cases occurred between 1969 and 1992. Results. Mean age at diagnosis of pheo was 39.5 years (range 14–68 years) in MEN 2A and 32.4 years (range 15–41 years) in MEN 2B patients. Pheo occurred first in 25.1% of the cases (2–15 years before diagnosis of MTC) and after MTC in 40.2% (2–11 years). In other cases (34.7%), MTC and pheo were diagnosed at the same time. Involvement was bilateral in 67.8% of cases. Malignancy was only 4%. Thirty‐nine deaths occurred in these 300 patients, 64.1% were linked in pheo, 23.1% to MTC and 12.8% to other causes. Surgery was unilateral in 39.7% of the cases and bilateral adrenalectomy was the first procedure in 48.4%. A bilateral adrenalectomy in two steps had to be done in 11.9% of cases. In conclusion, these results justify systematic and prolonged biochemical screening of pheo during follow‐up of MTC and address some questions about the best mode of surgery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2796.1995.tb01211.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 172

Metadata

Authors
Modigliani, E., VASEN, H. M., RAUE, K., DRALLE, H., FRILLING, A., GHERI, R. G., BRANDI, M. L., LIMBERT, E., NIEDERLE, B., FORGAS, L., ROSENBERG‐BOURGIN, M., CALMETTES, C., & THE EUROMEN STUDY GROUP
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
1995-10
Volume
238
Issue
4
Pages
363-367
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2167296999
Cited by
172
References
0
FWCI
6.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pheochromocytoma in multiple endocrine neoplasia type 2: European study. https://app.cochat.ai/papers/10.1111/j.1365-2796.1995.tb01211.x
The paper
Modigliani, E., VASEN, H. M., RAUE, K., DRALLE, H., FRILLING, A., GHERI, R. G., BRANDI, M. L., LIMBERT, E., NIEDERLE, B., FORGAS, L., ROSENBERG‐BOURGIN, M., CALMETTES, C., & THE EUROMEN STUDY GROUP. (1995). Pheochromocytoma in multiple endocrine neoplasia type 2: European study. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.1995.tb01211.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.